GSK’s chronic hepatitis B drug helps one in five achieve functional cure in key studies
More than 250 million people globally live with chronic hepatitis B.
Original Source
Read the full article at Straitstimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.